To hear about similar clinical trials, please enter your email below

Trial Title: Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer With Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial

NCT ID: NCT06288854

Condition: Weight Gain

Conditions: Official terms:
Body Weight
Weight Gain

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Intervention model description: olanzapine vs placebo

Primary purpose: Prevention

Masking: Single (Participant)

Intervention:

Intervention type: Other
Intervention name: weight gain each group
Description: weight gain after 12 Weeks
Arm group label: Olanzapine
Arm group label: Placebo

Other name: body weight

Summary: - Efficacy of olanzapine on weight gain in advanced stage gynecologic cancer - Proprotion of pateints in advanced stage gynecologic cancer who recieving paclitaxel and carboplatin chemotherapy gain weight on olanzapine or placebo

Detailed description: -Proprotion of pateints in advanced stage gynecologic cancer who recieving paclitaxel and carboplatin chemotherapy gain weight on olanzapine or placebo

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Advanced stage gynecologic cancer receiving Paclitaxel and carboplatin chemotherapy - ECOG 0-1 - Normal CBC,Liver, renal function - Communication in Thai language or Thai caregiver - Inform consent Exclusion Criteria: - Pregnancy - Active infection - Bowel obstruction or history of bowel surgery - On dopamine receptor antagonists or psychiatric or anticonvulsant medication - Olanzapine allery - Abnormal function of liver and renal - Diabetic melitus or morbid obesity - patient can't selfcare

Gender: Female

Minimum age: 18 Years

Maximum age: 70 Years

Healthy volunteers: Accepts Healthy Volunteers

Locations:

Facility:
Name: Rajavithi Hospital

Address:
City: Bangkok
Country: Thailand

Status: Recruiting

Contact:
Last name: Putsarat Insin

Phone: 022062900
Email: ec.rajavithihospital@gmail.com

Start date: April 3, 2024

Completion date: June 30, 2025

Lead sponsor:
Agency: Rajavithi Hospital
Agency class: Other

Source: Rajavithi Hospital

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06288854

Login to your account

Did you forget your password?